CURIS, INC. ANNOUNCES NEW CANCER PROGRAMS, FORMATION OF CHINA-BASED SUBSIDIARY

Curis, Inc., a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, announced that it has formed a wholly foreign-owned enterprise form of subsidiary in Shanghai, China. Earlier in 2006, Curis had initiated development work on several proprietary cancer programs through its relationship with Shanghai ChemPartner, a leading Chinese medicinal chemistry contract researcher. BioSpace (http://www.biospace.com/news_story.aspx?StoryID=29615&full=1)